English
简体中文
Total: £ 56.28
2026-02-12 | Pages: 134 | Tables: 132
The global Chairside Immediate Restoration Service market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.Chairside Immediate Restoration Service is an advanced oral restoration techn...
2026-02-12 | Pages: 101 | Tables: 101
The global CHO Cell Line Development Service market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.CHO Cell Line Development Service is a professional service for biopharmaceutical c...
2026-02-12 | Pages: 101 | Tables: 108
The global Radiopharmaceutical for Nuclear Medicine market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The North American market for Radiopharmaceutical for Nuclear Medicine is pr...
2026-02-12 | Pages: 103 | Tables: 109
The global Iodine Radioisotope market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The North American market for Iodine Radioisotope is projected to increase from US$ million in 20...
2026-02-12 | Pages: 109 | Tables: 104
The global Radioisotopes for Nuclear Medicine Diagnosis and Treatment market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The North American market for Radioisotopes for Nuclear Me...
2026-02-12 | Pages: 103 | Tables: 110
The global Radioactive Medical Isotopes market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The North American market for Radioactive Medical Isotopes is projected to increase from...
2026-02-12 | Pages: 154 | Tables: 152
The global Animal Gut Health Solutions market was valued at US$ 13990 million in 2025 and is anticipated to reach US$ 25400 million by 2032, at a CAGR of 9.0% from 2026 to 2032.Animal Gut Health Solutions refer to products, strategies, and practices ...
2026-02-12 | Pages: 111 | Tables: 120
The global Medical Device Engineering market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The North American market for Medical Device Engineering is projected to increase from US$...
2026-02-12 | Pages: 196 | Tables: 188
The global Clinical Safety and Pharmacovigilance Services market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.Clinical Safety and Pharmacovigilance Services encompass the processes...
2026-02-12 | Pages: 140 | Tables: 138
The global Clinical Endpoint Adjudication (CEA) market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.Clinical Endpoint Adjudication (CEA) is a crucial process in clinical trials, pa...
2026-02-12 | Pages: 118 | Tables: 112
The global Bioprinting market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.Bioprinting is an advanced form of 3D printing that involves the creation of biological structures using ...
2026-02-12 | Pages: 112 | Tables: 118
The global Human Procalcitonin Recombinant Protein market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.Human Procalcitonin Recombinant Protein is a human procalcitonin protein expr...
2026-02-12 | Pages: 102 | Tables: 104
The global CRP Polyclonal Antibody market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.CRP Polyclonal Antibody is a polyclonal antibody produced against C-reactive protein (CRP). C...
2026-02-12 | Pages: 116 | Tables: 120
The global Rubella Recombinant Antigen market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.Rubella Recombinant Antigen is a protein produced by genetic engineering technology that ...
2026-02-12 | Pages: 116 | Tables: 112
The global Toxoplasma Gondii Recombinant Antigen market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.Toxoplasma Gondii Recombinant Antigen is a protein produced by genetic engineer...
